Diagnostic tests

There’s no doubt that we have entered an era when important opportunities will exist to delay or diminish the symptoms of dementia. As we’ve been covering in agebuzz, there is now a new drug (Leqembi) available to delay impairment and decline in patients with mild cognitive impairment or the early…

We’ve all experienced it. Introduced to some new people in a social setting, you feel confused as to who was whom when discussing the gathering later that evening. Or, when asked a question, it takes you longer to retrieve the answer than it previously might have. Or maybe a friend…

As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…

It’s one of the most dreaded screening tests recommended for patients. In fact, you may remember that a recent survey found that the only thing worse for people than a colonoscopy was talking to relatives about the end of life! And yet colonoscopies indisputably save lives that would otherwise have…

September is World Alzheimer’s Month, and in recognition, it’s a good time to take stock of where things stand. In general, we continue to face a world where there are few effective treatments (and lots of continued controversy about Aduhelm, the recently FDA-approved treatment for Alzheimer’s, which many insurers and…

So here we are in September, with the Delta variant surging, schools re-opening, masks and vaccines being mandated, and boosters likely to be soon implemented. With all that going on it’s confusing as to how safe you are and what risks you face. We know that even if vaccinated, you…